Current location:World Watchers news portal > health
Is there anything Ozempic can't do? Now weight
World Watchers news portal2024-05-21 09:36:12【health】0People have gathered around
IntroductionAlready famed for helping thousands of Americans shift excess weight, Ozempic is now being tipped as
Already famed for helping thousands of Americans shift excess weight, Ozempic is now being tipped as a treatment for a myriad of other serious health problems.
In a new study, doctors found the blockbuster medication could slash the risk of developing multiple sclerosis (MS) by up to 80 percent.
Meanwhile, investigators are also launching research projects to determine if the drug could ease sleep apnea.
The researchers behind the MS study urged for immediate investigations to see if Ozempic could be a potential treatment for the neurodegenerative disorder.
The findings could be of even further financial benefit to the pharma firm behind the medicine, Novo Nordisk, with the obesity drugs market worth $80billion this year.
Doctors even went so far as to suggest semaglutide — the drug in Ozempic — should be investigated as a potential treatment for MS patients
The latest discoveries add to previous claims about wide-ranging benefits, such as slashing the risk of heart disease, kidney disease and problems with the liver. There are also suggestions they could cut the risk of Alzheimer's,
In the MS study, researchers from the University of Nebraska compared reports of MS in patients who'd taken 15 weight loss drugs — including semaglutide (the generic name for Ozempic).
Results showed those who used semaglutide had a 76 percent lower risk of developing MS compared to patients taking the other 14 drugs in the database, while for those using dulgaglutide, or Trulicity, this was 83.5 percent.
Want 'natural' Ozempic? Try eating your veggies before your meat
This routine, sometimes called nutrition cycling, has been known to slow the rate food leaves your stomach, keeping you fuller for longer.
AdvertisementA separate report also revealed that Eli Lilly, the drug firm working on tirzepatide, has launched a trial investigating how its drug impacts those with the common sleep condition, sleep apnea.
The condition, which affects around 39 million adults, causes patients to temporarily stop breathing while they sleep.
The study recruited nearly 500 patients who took the drug Mounjaro once a week. The trial was set to end last month, with results expected to be published in the coming months.
The weight loss triggered by the drug is expected to improve the condition — which can be worsened by excess fat in the neck area, which increases pressure on the upper airway.
Dr Angela Fitch, the current president of the Obesity Medicine Association, said: 'We already know it will work, it's just a question of how well.
'It will be interesting to see if those that lose more weight during th study get better remission of sleep apnea and how much weight loss is needed to put it in remission.'
It comes amid a weight loss treatments gold rush, with prescriptions of Ozempic and similar medications surging 300 percent between 2019 and 2022 alone.
They work by stimulating GLP-1 receptors in the brain, prompting someone to feel full even after a long period without eating anything.
This promise — of weight loss with just one injection a week — is what has fueled their popularity.
However, there are fears risks are being overlooked, with a DailyMail.com analysis of FDA data finding 117 fatalities linked to the drugs recorded since their release.
Among them was a woman in her 20s who was diagnosed with an 'intestinal mass', and another patient who was pregnant.
None of the deaths have been confirmed to have been caused by the drugs, but associations have been reported by patients.
In many cases, the alleged benefits are linked directly to the drug's ability to help people lose weight quickly.
Obesity can, overtime, damage a variety of tissues in the body, increasing the risk of developing a wide variety of diseases.
However, there is some research to suggest that some of the extensive benefits may be due to reasons other than weight loss.
The drug stimulated GLP-1 receptors found in other areas of the body, including the blood-brain-barrier.
Scientists have suggested that this can have a range of other effects including protecting nerve cells from damage.
In the study on MS, scientists analyzed medical data from more than 600,000 patients using 15 weight loss drugs since 2003.
They analyzed data from popular drugs like semaglutide and tirzepatide, as well as others linked to weight loss including metformin and bupropion.
Writing in the paper, published in Therapeutic Advances in Neurological Disorders, the team from the University of Nebraska wrote: 'Our findings suggest a potential consideration for repurposing anti-diabetic weight loss-inducing drugs including semaglutide... for MS.
'This warrants validation through rigorous methodologies and prospective studies.'
The study was funded by the University of Nebraska Medical Center.
Estimates show the market for weight loss medications has surged from $3billion in 2022 to more than $80billion today.
Novo Nordisk, behind Ozempic, was the first into the market. But Eli Lilly is catching up with its own weight loss drug tirzepatide, which is available as Mounjaro. Reports from last month suggested its weight loss drug Zepbound had already overtaken Wegovy in terms of prescriptions.
Ozempic has only been approved for type 2 diabetics so far, but it is often prescribed off-label for weight loss.
Its sister medication Wegovy — which uses the same drug semaglutide but in a lower dose — has been approved for treating weight loss and, earlier this year, also got the green light for heart disease patients.
Heart disease is the top killer in the US, with more than 120million adults estimated to be suffering from the condition.
Address of this article:http://pitcairnislands.downmusic.org/article-08d299986.html
Very good!(9734)
Related articles
- What's next for Iran after death of its president in crash?
- US House votes to remove wolves from endangered list in 48 states
- The Yellowstone effect! House prices in these rural Wyoming towns have soared to an all
- Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024
- Nadal returns to Roland Garros to practice amid doubts over fitness and form
- Chelsea Gray signs extension with 2
- Mississippi lawmakers quietly kill bills to restrict legal recognition of transgender people
- Rangers' Max Scherzer scratched from 2nd scheduled rehab start because of sore thumb
- Pentagon vows to keep weapons moving to Ukraine as Kyiv faces a renewed assault by Russia
- Rapper Quavo is mercilessly mocked after only a handful of fans turn up for Connecticut show
Popular articles
- Pope trip to Luxembourg, Belgium confirmed for September, 2 weeks after challenging Asia visit
- Steve Gleason, 47, reveals his daily 'exorcism' as he battles ALS: Ex
- Olympic refugee athlete Lohalith suspended in the team's 3rd doping case ahead of Paris Games
- Rangers' Max Scherzer scratched from 2nd scheduled rehab start because of sore thumb
Recommended
Medics remove 150 MAGGOTS from a woman's mouth after dental procedure left her with rotting tissue
Astros to option slumping 2020 AL MVP José Abreu to their spring training facility in Florida
Man United makes more executive changes as Jim Ratcliffe's new era takes shape
Georgia governor signs bill into law restricting land sales to some Chinese citizens
US overdose deaths dropped in 2023, the first time since 2018
Judge dismisses lawsuit against Saudi Arabia over 2019 Navy station attack
US House votes to remove wolves from endangered list in 48 states
Royal Troon to feature the longest hole in British Open history
Links
- José Ramírez homers, drives in 3 runs as AL Central
- China's top diplomat holds talks with Peru's foreign minister
- Arsenal are seen REHEARSING their Premier League trophy presentation
- Charlotte's Kahlina, Galaxy's Micovic untouchable in scoreless draw
- Israel intensifies offensive in Gaza, strikes 120 sites: army
- Standings undisturbed despite drama
- Bank of America trader, 25, dies suddenly 'of a cardiac arrest' during work event
- China, other countries to spur trade
- Missouri candidate with ties to the KKK can stay on the Republican ballot, judge rules
- Kate Moss snubs Buckingham Palace garden party after failing to turn up to star